Apolipoprotein E as a risk factor for coronary heart disease: A genetic and molecular biology approach

Current Opinion in Lipidology

Volumn 7, Issue 2, 1996, Pages 59-63

  De Knijff, Peter ^a,b,c   Havekes, Louis M ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; MEDICAL GENETICS; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0029970057     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199604000-00002     Document Type: Short Survey

References (41)

1. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8:1-21.
2. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
3. Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, Goldstein JL, Brown CB: Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 1982, 23:911-914.
4. de Knijff P, van den Maagdenberg AMJM, Frants RR, Havekes LM: Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 1994, 4:178-194.
5. Utermann G: Morgani lecture: genetic polymorphism of apolipoprotein E - impact on plasma lipoprotein metabolism. In Diabetes, obesity and hyperlipidemias vol 3. Edited by Crepaldi G, Tiengo A, Baggio G. Amsterdam: Elsevier; 1985: 1-28.
6. Dallongeville J, Lussier-Cacan S, Davignon J: Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 1992, 33: 447-454.
7. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazár A, Utermann G: The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991, 49:338-349.
8. de Knijff P, Johansen LG, Rosseneu M, Frants RR, Jespersen J, Havekes LM: Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, apoE and A4 polymorphism, and lifestyle. Arterioscler Thromb 1992, 12:1371-1379.
9. Sandholzer C, Delport R, Vermaak H, Utermann G: High frequency of the apo E4 allele in Khoi San from South Africa. Hum Genet 1995, 95:46-48.
10. Mahley RW, Palaoǧlu KE, Atak Z, Dawson-Pepin J, Langlois A-M, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F et al.: Turkish heart study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995, 36:839-859. By far the largest population-based study reporting influences of the apoE polymorphism on lipid levels performed to date. A very detailed article with much more information than can be discussed here.
11. Gajra B, Candlish JK, Saha N, Mak JW, Tay JSH: Effect of apolipoprotein E variants on plasma lipids and apolipoproteins in the Orang Asli ('aborigines') of Malaysia. Hum Hered 1994, 44:209-213.
12. Gajra B, Candlish JK, Saha N, Heng CK, Soemantri AG, Tay JSH: Influence of polymorphisms for apolipoprotein B (ins/del, Xbal, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population. Genet Epidemiol 1994, 11:19-27.
13. Kao J-T, Tsai K-S, Chang C-J, Huang P-C: The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995, 114:55-59.
14. Lehtimäki T, Moilanen T, Porkka K, Åkerblom HK, Rönnemaa T, Räsänen L, Viikari J, Ehnholm C, Nikkari T: Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: the Cardiovascular Risk in Young Finns Study. J Lipid Res 1995, 36:653-661. A very convincing study presenting evidence that dietary intake of fats influences apoE phenotype specific effects on circulating levels of lipids.
15. Kamboh MI, Aston CE, Hamman RF: The relationship of apoE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 1995, 112:145-159.
16. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PWF: Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham offspring study. Arterioscler Thromb 1994, 14:1105-1113.
17. Hegele RA, Evans AJ, Tu L, Ip G, Brunt H, Conelly PW: A gene-gender interaction affecting plasma lipoproteins in a genetic isolate. Arterioscler Thromb 1994, 14:671-678.
18. Reilly SL, Ferrel RE, Sing CF: The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III: correlations and covariances. Am J Hum Genet 1994, 55:1001-1018. The third article in an important and original series, providing very detailed insight into the specific role of apoE in determining circulating levels of lipids.
19. Luc G, Bard J-M, Arveiler D, Evans A, Cambou J-P, Bingham A, Amouyel P, Schaffer P, Ruidavets J-B, Cambien F et al.: Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1994, 14:1412-1419.
20. Tiret L, de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes LM, for the EARS group: ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. Arterioscler Thromb 1994, 14:1617-1624.
21. Hixson JE, and the pathobiological determinants of atherosclerosis in youth (PDAY) research group: Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb 1991, 11: 1237-1244.
22. Damaraju S, Yu QT, Safavi F, Marian AJ: Apolipoprotein E4 is not a risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995, 75:1181-1183.
23. de Knijff P, Jansen H, Lie KI, Havekes LM: Apolipoprotein E4 and coronary artery disease [Letter]. Lancet 1992, 340:1351.
24. Lehtinen S, Lehtimäki T, Sisto T, Salenius J-P, Nikkilä M, Jokela H, Koivula T, Ebeling F, Ehnholm C: Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 1995, 114:83-91.
25. Wang XL, McCredie RM, Wilcken DEL: Polymorphism of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol 1995, 15:1030-1034.
26. Scheer WD, Boudreau DA, Malcom GT, Middaugh JP: Apolipoprotein E and atherosclerosis in Alaska Natives. Atherosclerosis 1995, 114: 197-202.
27. de Andrade M, Thandi I, Brown S, Gotto A Jr, Patsch W, Boerwinkle E: Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 1995, 56:1379-1390.
28. 4 confers a risk factor for CHD only in females.
29. 4 carriers are at a higher risk for developing a lethal myocardral infarction.
30. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140.
31. Van Ree JH, Gijbels MJ, Van den Broek WJ, Hofker MH, Havekes LM: Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding. Atherosclerosis 1995, 112:237-243.
32. Feingold KR, Elias PM, Mao-Qiang M, Fartasch M, Zhang SH, Maeda N: Apolipoprotein E deficiency leads to cutaneous foam cell formation in mice. J Inv Dermatol 1995, 104:246-250.
33. Hayek T, Oiknine J, Brook JG, Aviram M: Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apoE knockout transgenic mice. Biochim Biophys Res Commun 1994, 205:1072-1078.
34. Linton MF, Atkinson JB, Fazio S: Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 1995, 267:1034-1037.
35. Boisvert WA, Spangenberg J, Curtiss LK: Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest 1995, 96:1118-1124.
36. Kashyap VS, Santamarinafojo S, Brown DR, Parrott CL, Applebaum-Bowden D, Meyn S, Talley G, Paigen B, Maeda N, Brewer HB: Apolipoprotein E-deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest 1995, 96:1612-1620.
37. Yamamoto K, Shimano H, Shimada M, Kawamura M, Gotoda T, Harada K, Ohsuga J, Yazaki Y, Yamada N: Overexpression of apolipoprotein E prevents development of diabetic hyperlipidemia in transgenic mice. Diabetes 1995, 44:580-585.
38. Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K, Katsuki M, Yazaki Y, Yamada N: Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest 1995, 95:469-476.
39. Van Vlijmen BJ, Van den Maagdenberg AM, Gijbels MJ, Van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM: Diet-induced hyperlipo-proteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 1994, 93:1403-1410.
40. Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC Jr: Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E (Arg 112, Cys 142). Arterioscler Thromb 1994, 14:1873-1879.
41. 4 on the clearance of chylomicron-like lipid emulsions and atherogenesis in transgenic mice. Arterioscler Thromb 1994, 14:1542-1552.